INGN - Inogen, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Goleta,
United States
Type: Equity
INGN price evolution
INGN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $101.48 | $107.44 | $125.49 | |
| Short term investments | $19.77 | $12.36 | $2.98 | |
| Net receivables | $35.2 | $36.04 | $40.22 | $42.24 |
| Inventory | $23.32 | $24.05 | $24.6 | $21.84 |
| Total current assets | $192.55 | $194.79 | $199.19 | $207.07 |
| Long term investments | ||||
| Property, plant & equipment | $65.61 | $66.97 | $69.84 | $70.65 |
| Goodwill & intangible assets | $43.35 | $42.74 | $44.65 | |
| Total noncurrent assets | $114.13 | $116.41 | $119.13 | |
| Total investments | $19.77 | $12.36 | $2.98 | |
| Total assets | $306.17 | $308.92 | $315.6 | $326.19 |
| Current liabilities | ||||
| Accounts payable | $22.72 | $26.78 | $31.71 | $30.14 |
| Deferred revenue | $14.45 | $15.04 | $16.21 | |
| Short long term debt | $3.33 | $3.52 | $3.65 | |
| Total current liabilities | $72.4 | $72.19 | $73.91 | $72.5 |
| Long term debt | $18.11 | $18.59 | $18.27 | |
| Total noncurrent liabilities | $49.14 | $49.79 | $48.89 | |
| Total debt | $21.44 | $22.11 | $21.92 | |
| Total liabilities | $120.77 | $121.32 | $123.7 | $121.38 |
| Shareholders' equity | ||||
| Retained earnings | -$143.08 | -$137.12 | -$131.53 | -$116.95 |
| Other shareholder equity | $1.42 | -$0.14 | $0.19 | $1.23 |
| Total shareholder equity | $187.59 | $191.9 | $204.81 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $125.49 | $187.01 | $235.52 | $211.96 |
| Short term investments | $2.98 | $9.99 | $19.26 | |
| Net receivables | $42.24 | $64.35 | $24.45 | $29.72 |
| Inventory | $21.84 | $34.09 | $31.87 | $24.82 |
| Total current assets | $207.07 | $304.64 | $329.19 | $305.7 |
| Long term investments | ||||
| Property, plant & equipment | $70.65 | $64.92 | $63.84 | $37.06 |
| Goodwill & intangible assets | $44.65 | $33.03 | $93.13 | $101.96 |
| Total noncurrent assets | $119.13 | $100.4 | $160.33 | $156.16 |
| Total investments | $2.98 | $9.99 | $19.26 | |
| Total assets | $326.19 | $405.04 | $489.51 | $461.85 |
| Current liabilities | ||||
| Accounts payable | $30.14 | $29.07 | $25.69 | $33.71 |
| Deferred revenue | $16.21 | $19.28 | $20.43 | $18.82 |
| Short long term debt | $3.65 | $3.52 | $3.39 | $1.93 |
| Total current liabilities | $72.5 | $65.35 | $61.51 | $56.71 |
| Long term debt | $18.27 | $19.76 | $23.28 | $8.08 |
| Total noncurrent liabilities | $48.89 | $42.29 | $57.77 | $55.52 |
| Total debt | $21.92 | $23.28 | $26.67 | $10.01 |
| Total liabilities | $121.38 | $107.64 | $119.29 | $112.23 |
| Shareholders' equity | ||||
| Retained earnings | -$116.95 | -$14.5 | $69.27 | $75.61 |
| Other shareholder equity | $1.23 | -$0.27 | $1.47 | $0.47 |
| Total shareholder equity | $204.81 | $297.41 | $370.23 | $349.62 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $88.77 | $78.03 | $75.9 | |
| Cost of revenue | $46.03 | $43.65 | $47.74 | |
| Gross Profit | $42.74 | $34.37 | $28.16 | |
| Operating activities | ||||
| Research & development | $5.62 | $6.58 | $6.71 | |
| Selling, general & administrative | $44.19 | $44.07 | $50.43 | |
| Total operating expenses | $49.8 | $50.65 | $57.14 | |
| Operating income | -$7.06 | -$16.27 | -$28.98 | |
| Income from continuing operations | ||||
| EBIT | -$5.6 | -$14.73 | -$27.09 | |
| Income tax expense | -$0.01 | -$0.15 | -$0.53 | |
| Interest expense | ||||
| Net income | ||||
| Net income | -$5.59 | -$14.58 | -$26.55 | |
| Income (for common shares) | -$5.59 | -$14.58 | -$26.55 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $315.66 | $377.24 | $358 | $308.49 |
| Cost of revenue | $188.96 | $223.71 | $181.52 | $170.31 |
| Gross Profit | $126.7 | $153.53 | $176.48 | $138.18 |
| Operating activities | ||||
| Research & development | $20.84 | $21.94 | $16.58 | $14.08 |
| Selling, general & administrative | $182.35 | $164.67 | $150.67 | $136.13 |
| Total operating expenses | $236.09 | $238.78 | $167.24 | $150.21 |
| Operating income | -$109.39 | -$85.24 | $9.24 | -$12.03 |
| Income from continuing operations | ||||
| EBIT | -$102.34 | -$83.27 | $8.66 | -$5.28 |
| Income tax expense | $0.1 | $0.5 | $14.99 | $0.55 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$102.45 | -$83.77 | -$6.33 | -$5.83 |
| Income (for common shares) | -$102.45 | -$83.77 | -$6.33 | -$5.83 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$5.59 | -$14.58 | -$26.55 | |
| Operating activities | ||||
| Depreciation | $5.34 | $5.26 | $5.14 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.81 | $2.42 | -$1.06 | |
| Total cash flows from operations | $6.69 | -$4.75 | -$3.15 | |
| Investing activities | ||||
| Capital expenditures | -$4.97 | -$4.13 | -$6.3 | |
| Investments | -$7.45 | -$9.38 | $10.38 | |
| Total cash flows from investing | -$25.52 | -$12.38 | -$13.44 | $4.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.37 | |||
| Net borrowings | ||||
| Total cash flows from financing | $0.53 | -$0.2 | $0.28 | -$0.01 |
| Effect of exchange rate | -$0.15 | -$0.08 | -$0.14 | -$0.08 |
| Change in cash and equivalents | -$16.21 | -$5.96 | -$18.05 | $0.88 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$102.45 | -$83.77 | -$6.33 | -$5.83 |
| Operating activities | ||||
| Depreciation | $18.15 | $23.51 | $21.63 | $18.58 |
| Business acquisitions & disposals | -$29.63 | |||
| Stock-based compensation | $7.43 | $12.28 | $10.94 | $8.2 |
| Total cash flows from operations | -$3.23 | -$37.53 | $23.63 | $37.01 |
| Investing activities | ||||
| Capital expenditures | -$27.01 | -$21.22 | -$24.07 | -$17.6 |
| Investments | -$2.87 | $10.01 | $9.27 | -$8.21 |
| Total cash flows from investing | -$59.31 | -$10.88 | -$14.64 | -$25.64 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.48 | $1.74 | $15.65 | $2.42 |
| Net borrowings | ||||
| Total cash flows from financing | $0.96 | $0.38 | $15 | $2.07 |
| Effect of exchange rate | $0.07 | -$0.48 | -$0.43 | $0.49 |
| Change in cash and equivalents | -$61.52 | -$48.51 | $23.56 | $13.93 |
News
Fundamentals
| Market cap | $147.67M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 23.82M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.59 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.66 |
| Quick ratio | 2.34 |